THOXDRO

Dead / Abandoned — Abandoned — no statement of use filed (as of 06 Jul 2026)

What this means for you

This application is over — abandoned 06 Jul 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
99129316
Mark type
Word mark
Filed
09 Apr 2025
Published for opposition
07 Oct 2025
Abandoned
06 Jul 2026
Attorney of record
Joshua G. Gigger

Goods and services

  • Class 005 — Pharmaceuticals: pharmaceutical products for the treatment of central nervous system diseases and disorders; pharmaceutical products for the treatment of vertigo, dizziness, and lightheadedness; pharmaceutical products for the treatment of symptomatic neurogenic orthostatic hypotension; pharmaceutical products for the treatment of symptoms caused by primary autonomic failure, dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy; pharmaceutical products for the treatment of symptoms caused by Parkinson’s disease, multiple system atrophy, and pure autonomic failure

Owner

Prosecution history

  • 06 Jul 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 06 Jul 2026 — ABANDONMENT - NO USE STATEMENT FILED
  • 02 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 07 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 07 Oct 2025 — PUBLISHED FOR OPPOSITION
  • 01 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 04 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 04 Sept 2025 — ASSIGNED TO EXAMINER
  • 09 Apr 2025 — APPLICATION FILING RECEIPT MAILED
  • 09 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 09 Apr 2025 — NEW APPLICATION ENTERED

View this trademark record on Rightsy